STRO
Sutro Biopharma
16.40$
+6.6%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -612.7% | – | – | – | -3,245.0% | – | – | |
| – | -11.9% | -9.0% | +5.2% | -10.0% | +12.7% | +17.5% | +19.8% | +5.9% | +1.5% | |
| – | +43.7% | +106.5% | +259.1% | +15.6% | +95.0% | +13.2% | -5.3% | -0.9% | -43.3% | |
| – | +295.1% | -32.7% | +250.0% | -367.1% | – | -65.4% | – | – | – | |
| – | – | – | -154.6% | – | – | – | -132.9% | – | -666.3% | |
| – | -24.5% | -53.0% | +123.6% | +104.8% | +114.9% | -48.7% | -45.1% | -28.2% | -45.3% | |
| – | +239.9% | -346.0% | -36.2% | – | -16,211.8% | -64.0% | -88.8% | – | -79.4% | |
| – | – | – | – | +5.7% | – | – | – | – | – | |
| – | +8,103.8% | +459.4% | -100.4% | -4.0% | -97.8% | +6,514.3% | +5.8% | – | – | |
| – | +0.0% | -133.3% | +0.0% | – | -162.5% | +0.0% | +33.3% | -67.3% | -100.0% | |
| – | +8,170.6% | +1,066.6% | -102.4% | – | -98.8% | +1,383.8% | +184.7% | -31.6% | -100.0% | |
| – | – | +915.8% | -216.5% | – | -187.0% | – | +30.7% | +449.8% | -209.2% | |
| – | – | – | -715.7% | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.